Kestra Advisory Services’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Kestra Advisory Services’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,643	Closed	-$3.62K	–	3363
2026 Q1	$3.62K	Buy	+14,643	New	+$5.83K	﹤0.01%	3111
2025 Q3	–	Sell	-14,643	Closed	-$7.93K	–	3013
2025 Q2	$7.93K	Buy	+14,643	New	+$8.7K	﹤0.01%	2812
2022 Q3	–	Sell	-11,518	Closed	-$48K	–	2227
2022 Q2	$48K	Buy	+11,518	New	+$49.8K	﹤0.01%	2045

Other funds holding SGMO

AIM

Axiom Investment Management New York $150M AUM

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Kestra Advisory Services's SGMO Position: Q2 2026 in Review

Kestra Advisory Services sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 14,643 shares — an estimated $3.62K sold.

Kestra Advisory Services first reported a position in SGMO in Q2 2022 and held it in 3 quarters. The position peaked at $48K in Q2 2022. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Kestra Advisory Services reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Kestra Advisory Services sold 14,643 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $3.62K.
Kestra Advisory Services first reported a position in SANGAMO THERAPEUTICS INC in Q2 2022 and held it in 3 quarters.
Kestra Advisory Services's SANGAMO THERAPEUTICS INC position peaked at $48K in Q2 2022.
2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.